Short-Acting Insulin Global Market Report 2025

Global Short-Acting Insulin Market Report 2025

Short-Acting Insulin Global Market Report 2025 - By Formulation (Regular Insulin, Rapid-Acting Insulin), By Dosage Form (Vials, Pre-filled Pens, Cartridges), By Route Of Administration (Subcutaneous, Intravenous), By Patient Type (Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel (Pharmacies, Hospital Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Name: Short-Acting Insulin Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Short-Acting Insulin Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Short-Acting Insulin Global Market Report 2025

Proud Members Of

What Is Covered Under Short-Acting Insulin Market

Short-acting insulin is a type of insulin that is used to control blood sugar levels during or after meals. It begins to work within 30 minutes to 1 hour, peaks at around 2-3 hours, and has a duration of action of 4-6 hours. Short-acting insulin plays a vital role in regulating blood glucose by facilitating the uptake of glucose into cells, which the body then uses for energy, particularly after the consumption of food.

The main formulation types of short-acting insulin are regular insulin and rapid-acting insulin. Regular insulin is a fast-acting form of insulin used to control blood sugar levels in people with diabetes, typically administered before meals. These formulations are available in different dosage forms, including vials, pre-filled pens, and cartridges, and are administered through subcutaneous or intravenous routes. It is prescribed for both type 1 and type 2 diabetes patients and distributed through various channels, such as retail pharmacies, hospital pharmacies, and online pharmacies.

How Is The Short-Acting Insulin Market Segmented?

The short-acting insulin market covered in this report is segmented –

1) By Formulation: Regular Insulin, Rapid-Acting Insulin

2) By Dosage Form: Vials, Pre-filled Pens, Cartridges

3) By Route Of Administration: Subcutaneous, Intravenous

4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes

5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies

Subsegments:

1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin

2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine

Short-Acting Insulin Market Size and growth rate 2025 to 2029: Graph

What Is The Short-Acting Insulin Market Size 2025 And Growth Rate?

The short-acting insulin market size has grown strongly in recent years. It will grow from $11.00 billion in 2024 to $11.65 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to an increase in the type 1 diabetes population, a rising geriatric population, a surge in research and development funding, the prevalence of diagnosed instances, and increasing urbanization.

What Is The Short-Acting Insulin Market Growth Forecast?

The short-acting insulin market size is expected to see strong growth in the next few years. It will grow to $14.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to an increase in initiatives taken by the government, an increase in government support, rapid innovations in production, increasing adoption of insulin therapy, and the rise of personalized medicine. Major trends in the forecast period include advancements in insulin delivery devices and technologies, innovative fast-acting insulin analogs, the development of biosimilars, a shift towards patient-centric care, and advancements in formulation.

Book your 30 minutes free consultation with our research experts

What Is Driving The Short-Acting Insulin Market: Surging Type 1 Diabetes Prevalence Highlights Need For Effective Insulin Therapy

The increasing prevalence of type 1 diabetes is expected to fuel the growth of the short-acting insulin market going forward. Type 1 diabetes is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy. The rising prevalence of Type 1 diabetes is driven by genetic factors, environmental triggers, and increasing autoimmune disorders. Short-acting insulin helps manage type 1 diabetes by providing rapid blood sugar control and mimicking natural insulin response. For instance, in 2023, according to Diabetes Australia, an Australia-based organization that works to raise awareness about diabetes, in 2022, approximately 134,000 Australians were living with Type 1 diabetes. This figure increased to 135,423 in 2023. Therefore, the increasing prevalence of type 1 diabetes is driving the growth of the short-acting insulin market.

Who Are The Major Players In The Global Short-Acting Insulin Market?

Major companies operating in the short-acting insulin market are Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Baxter International Inc., Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Biocon Limited, Kissei Pharmaceutical Co. Ltd., Lupin Limited, Wockhardt Ltd., Lannett Co. Inc., MannKind Corporation, Sihuan Pharmaceutical Holdings Group Ltd., Julphar(Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., hec pharm co. ltd, ADOCIA SAS, Gan & Lee Pharmaceuticals Co. Ltd., Adocia S.A.S.

What Are The Key Trends Of The Global Short-Acting Insulin Market: Innovative Wearable Insulin Pod Gains FDA Clearance For Type 2 Diabetes

Major companies operating in the short-acting insulin market are focusing on innovative products such as insulin pods to provide continuous insulin infusion and adherence for individuals with diabetes. An insulin pod refers to a tubeless, wearable insulin delivery system that provides continuous insulin infusion for diabetes management. For instance, in April 2023, Insulet Corporation, a US-based medical device company, announced U.S. Food and Drug Administration (FDA) clearance for Omnipod GO, a groundbreaking basal-only insulin pod designed for adults with type 2 diabetes. This tubeless, wearable device offers continuous insulin delivery without the need for a separate controller. Omnipod GO simplifies diabetes management by eliminating daily injections and providing pre-programmed insulin rates. With its user-friendly design and pharmacy accessibility, it enhances convenience for both patients and healthcare providers. This launch reinforces Insulet's commitment to improving diabetes care through innovative technology.

What Are Latest Mergers And Acquisitions In The Short-Acting Insulin Market: Lupin Strengthens Diabetes Care With Hum Insulin Acquisition

In December 2024, Lupin Limited, an India-based pharmaceutical company, acquired the Humulin range in India from Eli Lilly & Company for an undisclosed amount. With this acquisition, Lupin aims to strengthen its position in the insulin market in India by expanding its product portfolio with the addition of Huminsulin from Eli Lilly and Company. Eli Lilly and Company is a US-based pharmaceutical company specializing in insulin products such as short-acting insulin.

What Is The Regional Outlook For The Global Short-Acting Insulin Market?

North America was the largest region in the short-acting insulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short-acting insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the short-acting insulin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Short-Acting Insulin Market?

The short-acting insulin market consists of sales of human insulin, analogue insulin, and biosimilars. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Short-Acting Insulin Industry?

The short-acting insulin market research report is one of a series of new reports from The Business Research Company that provides short-acting insulin market statistics, including the short-acting insulin industry global market size, regional shares, competitors with the short-acting insulin market share, detailed short-acting insulin market segments, market trends, and opportunities, and any further data you may need to thrive in the short-acting insulin industry. This short-acting insulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

ShortActing Insulin Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$11.65 billion
Revenue Forecast In 2034	$14.47 billion
Growth Rate	CAGR of 5.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The short-acting insulin market covered in this report is segmented – 1) By Formulation: Regular Insulin, Rapid-Acting Insulin 2) By Dosage Form: Vials, Pre-filled Pens, Cartridges 3) By Route Of Administration: Subcutaneous, Intravenous 4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes 5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies Subsegments: 1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin 2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Baxter International Inc., Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Biocon Limited, Kissei Pharmaceutical Co. Ltd., Lupin Limited, Wockhardt Ltd., Lannett Co. Inc., MannKind Corporation, Sihuan Pharmaceutical Holdings Group Ltd., Julphar(Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., hec pharm co. ltd, ADOCIA SAS, Gan & Lee Pharmaceuticals Co. Ltd., Adocia S.A.S.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Short-Acting Insulin Market Characteristics

3. Short-Acting Insulin Market Trends And Strategies

4. Short-Acting Insulin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Short-Acting Insulin Growth Analysis And Strategic Analysis Framework

5.1. Global Short-Acting Insulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Short-Acting Insulin Market Growth Rate Analysis

5.4. Global Short-Acting Insulin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Short-Acting Insulin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Short-Acting Insulin Total Addressable Market (TAM)

6. Short-Acting Insulin Market Segmentation

6.1. Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Regular Insulin

Rapid-Acting Insulin

6.2. Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vials

Pre-filled Pens

Cartridges

6.3. Global Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subcutaneous

Intravenous

6.4. Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Type 1 Diabetes

Type 2 Diabetes

6.5. Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmacies

Hospital Pharmacies

Online Pharmacies

6.6. Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Regular Insulin

Animal-Derived Regular Insulin

Other Regular Insulin

6.7. Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Insulin Lispro

Insulin Aspart

Insulin Glulisine

7. Short-Acting Insulin Market Regional And Country Analysis

7.1. Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Short-Acting Insulin Market

8.1. Asia-Pacific Short-Acting Insulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Short-Acting Insulin Market

9.1. China Short-Acting Insulin Market Overview

9.2. China Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Short-Acting Insulin Market

10.1. India Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Short-Acting Insulin Market

11.1. Japan Short-Acting Insulin Market Overview

11.2. Japan Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Short-Acting Insulin Market

12.1. Australia Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Short-Acting Insulin Market

13.1. Indonesia Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Short-Acting Insulin Market

14.1. South Korea Short-Acting Insulin Market Overview

14.2. South Korea Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Short-Acting Insulin Market

15.1. Western Europe Short-Acting Insulin Market Overview

15.2. Western Europe Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Short-Acting Insulin Market

16.1. UK Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Short-Acting Insulin Market

17.1. Germany Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Short-Acting Insulin Market

18.1. France Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Short-Acting Insulin Market

19.1. Italy Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Short-Acting Insulin Market

20.1. Spain Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Short-Acting Insulin Market

21.1. Eastern Europe Short-Acting Insulin Market Overview

21.2. Eastern Europe Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Short-Acting Insulin Market

22.1. Russia Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Short-Acting Insulin Market

23.1. North America Short-Acting Insulin Market Overview

23.2. North America Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Short-Acting Insulin Market

24.1. USA Short-Acting Insulin Market Overview

24.2. USA Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Short-Acting Insulin Market

25.1. Canada Short-Acting Insulin Market Overview

25.2. Canada Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Short-Acting Insulin Market

26.1. South America Short-Acting Insulin Market Overview

26.2. South America Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Short-Acting Insulin Market

27.1. Brazil Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Short-Acting Insulin Market

28.1. Middle East Short-Acting Insulin Market Overview

28.2. Middle East Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Short-Acting Insulin Market

29.1. Africa Short-Acting Insulin Market Overview

29.2. Africa Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Short-Acting Insulin Market Competitive Landscape And Company Profiles

30.1. Short-Acting Insulin Market Competitive Landscape

30.2. Short-Acting Insulin Market Company Profiles

30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Short-Acting Insulin Market Other Major And Innovative Companies

31.1. Sumitomo Pharma Co. Ltd.

31.2. Biocon Limited

31.3. Kissei Pharmaceutical Co. Ltd.

31.4. Lupin Limited

31.5. Wockhardt Ltd.

31.6. Lannett Co. Inc.

31.7. MannKind Corporation

31.8. Sihuan Pharmaceutical Holdings Group Ltd.

31.9. Julphar(Gulf Pharmaceutical Industries)

31.10. Geropharm LLC

31.11. Bioton S.A.

31.12. hec pharm co. ltd

31.13. ADOCIA SAS

31.14. Gan & Lee Pharmaceuticals Co. Ltd.

31.15. Adocia S.A.S.

32. Global Short-Acting Insulin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Short-Acting Insulin Market

34. Recent Developments In The Short-Acting Insulin Market

35. Short-Acting Insulin Market High Potential Countries, Segments and Strategies

35.1 Short-Acting Insulin Market In 2029 - Countries Offering Most New Opportunities

35.2 Short-Acting Insulin Market In 2029 - Segments Offering Most New Opportunities

35.3 Short-Acting Insulin Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Sanofi S.A. Financial Performance

Table 79: Eli Lilly and Company Financial Performance

Table 80: Novo Nordisk A/S Financial Performance

Table 81: Baxter International Inc. Financial Performance

Table 82: Eisai Co. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Sanofi S.A. Financial Performance

Figure 79: Eli Lilly and Company Financial Performance

Figure 80: Novo Nordisk A/S Financial Performance

Figure 81: Baxter International Inc. Financial Performance

Figure 82: Eisai Co. Ltd. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth

Traditional Radio Advertising Market 2023 – By Type (Terrestrial Radio Broadcast Advertising, Satellite Radio Advertising), By Enterprise Size (Large Enterprise, Small And Medium Enterprise), By Industry Vertical (Automotive, Financial Services, Media And Entertainment, Fast-Moving Consumer Goods (FCMG), Retail, Real Estate, Education, Other Industry Verticals), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Surgical Sealants And Adhesives Market 2022 – By Product (Biological Sealants, Synthetic Sealants, Semi-Synthetic Sealants), By Indication (Tissue Sealing, Tissue Engineering, Hemostasis), By End Use (Hospital, Clinics), And By Region, Opportunities And Strategies – Global Forecast To 2031

View Report

Aerospace Couplers Global Market Report 2025 – By Type (Emergency Breakaway Coupler, Pressure Coupler, Hydrant Coupler), By Application (Commercial, Military) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Insulin Drugs Global Market Report 2025 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And Human Insulin), By Drug Classification (Branded Drugs, And Generic Drugs), By Application (Type 2 Diabetes, Type 1 Diabetes, And Gestational Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Smart Insulin Pens Global Market Report 2025 – By Type (First Generation Pens, Second Generation Pens), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2025 – By Type (Pens, Injectors And Pumps, Syringes), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps), By End Users (Hospitals, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Storage Tank Global Market Report 2025 – By Type (Aboveground Storage Tanks, Underground Storage Tanks), By Material (Steel, Concrete, Polyethylene, Other Materials), By Application (Petroleum Industry, Chemical Industry, Grain and Oil Industry, Food Industry, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Large Cooking Appliance Global Market Report 2025 – By Product( Cooktops, Ovens, Specialized Appliances), By Sales Channel( Brick And Mortar, E-Commerce), By Application( Household, Commercial) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Short-Acting Insulin market?

How will the Short-Acting Insulin market drivers and restraints affect the market dynamics? What forces will shape the Short-Acting Insulin industry going forward?

The Short-Acting Insulin market major growth driver - Surging Type 1 Diabetes Prevalence Highlights Need For Effective Insulin Therapy. For further insights on the Short-Acting Insulin market, request a sample here

What is the forecast market size or the forecast market value of the Short-Acting Insulin market?

The Short-Acting Insulin market size has grown strongly in recent years. The short-acting insulin market size has grown strongly in recent years. It will grow from $11.00 billion in 2024 to $11.65 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to an increase in the type 1 diabetes population, a rising geriatric population, a surge in research and development funding, the prevalence of diagnosed instances, and increasing urbanization. The short-acting insulin market size is expected to see strong growth in the next few years. It will grow to $14.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to an increase in initiatives taken by the government, an increase in government support, rapid innovations in production, increasing adoption of insulin therapy, and the rise of personalized medicine. Major trends in the forecast period include advancements in insulin delivery devices and technologies, innovative fast-acting insulin analogs, the development of biosimilars, a shift towards patient-centric care, and advancements in formulation. For further insights on the Short-Acting Insulin market, request a sample here

How is the Short-Acting Insulin market segmented?

The short-acting insulin market covered in this report is segmented –
1) By Formulation: Regular Insulin, Rapid-Acting Insulin
2) By Dosage Form: Vials, Pre-filled Pens, Cartridges
3) By Route Of Administration: Subcutaneous, Intravenous
4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes
5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies

Subsegments:
1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin
2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine For further insights on the Short-Acting Insulin market, request a sample here

Which region has the largest share of the Short-Acting Insulin market? What are the other regions covered in the report?

Who are the major players in the Short-Acting Insulin market?

What are the key trends in the Short-Acting Insulin market?

Major trends in the Short-Acting Insulin market include Innovative Wearable Insulin Pod Gains FDA Clearance For Type 2 Diabetes. For further insights on the Short-Acting Insulin market, request a sample here.

What are the major opportunities in the Short-Acting Insulin market? What are the strategies for the Short-Acting Insulin market?

For detailed insights on the major opportunities and strategies in the Short-Acting Insulin market, request a sample here.

How does the Short-Acting Insulin market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Short-Acting Insulin market growth and SWOT analysis of the Short-Acting Insulin industry, request a sample here.

For detailed insights on Short-Acting Insulin's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Short-Acting Insulin industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Short-Acting Insulin industry,

What are the key dynamics influencing the Short-Acting Insulin market growth? SWOT analysis of the Short-Acting Insulin market. request a sample here.